Galmed Pharma (GLMD) Says ARRIVE Trial Did Not Meet its Primary Endpoint
Tweet Send to a Friend
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("GalmedĖ® or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
